Further, the high variability of cfDNA and ctDNA yields between individual mice in each of the MLL-r ALL PDXs is supported by previous reports of patients with seemingly similar disease classifications exhibiting varied responses and outcomes [39,40]. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.